Skip to main content

Other current therapy areas

Paediatric endocrinology

Interested in paediatric endocrinology?

Visit our dedicated microsite for research news, interviews and in-depth analysis of paediatric endocrinology and growth disorders.

  • Parental heights of Turner syndrome patients aid diagnosis, but are seldom measured

  • Severe hypoglycaemia risk remains high years after previous episode in children with diabetes


01-02-2018 | HBV | News | Article

Diabetes linked to elevated HCC risk after HBsAg seroclearance

Diabetes remains an independent risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection even after hepatitis B surface antigen seroclearance, findings indicate.

01-02-2018 | HBV | News | Article

Estimates of HBV carrier numbers in Japan released

Japanese researchers have generated a nationwide estimate of total numbers of hepatitis B virus carriers and treated patients in 2011, comparing it with earlier estimates from 2000.

22-12-2017 | HBV | News | Article

FIB-4 index identifies chronic HBV patients with lowest HCC risk

The noninvasive fibrosis-4 index can further refine the existing favorable clinical profile for hepatocellular carcinoma risk in noncirrhotic patients with chronic hepatitis B virus infection and help identify those with the lowest risk, say researchers.


12-03-2018 | Asthma | News | Article

Exacerbation frequency linked to lung function decline in severe eosinophilic asthma

Repeated exacerbations in patients with severe eosinophilic asthma may be associated with accelerated deterioration of lung function, study findings show.

13-02-2018 | Asthma | News | Article

Initiation criteria for mepolizumab sufficient for determining long-term benefit

Researchers have been unable to find a reliable rule for identifying patients who are likely to benefit from continued long-term mepolizumab treatment for severe eosinophilic asthma.

16-01-2018 | Asthma | News | Article

Allergic airway inflammation stimulates a dynamic ILC2 phenotype

Researchers have found that the group 2 innate lymphoid cell phenotype is more heterogeneous than previously thought, with a surface marker and gene expression profile that is highly dynamic.


24-04-2018 | Rheumatology | News | Article

Pain, comorbidity burden high in patients with spondyloarthritis

Results of two studies emphasize the important of taking pain and comorbidities into account when treating patients with spondyloarthritis.

23-04-2018 | Rheumatology | News | Article

Verinurad–febuxostat combination shows promise for the treatment of gout

Results of a phase IIa trial support further investigation of the selective URAT1 inhibitor verinurad in combination with febuxostat for the treatment of gout.

20-04-2018 | Rheumatology | News | Article

JIA recommendations define treat-to-target strategy

An international taskforce has developed consensus recommendations for treating juvenile idiopathic arthritis to target.

image credits